abstract |
Compounds and pharmaceutical compositions that modulate kinase activity comprising mutant EGFR and mutant HER2 kinase activity, and compounds, pharmaceutical compositions and pharmaceutical compositions for treatment of diseases and conditions associated with kinase activity comprising mutant EGFR and mutant HER2 activity; Methods are described herein. |